tremfya
janssen-cilag international nv - guselkumab - psoriasis - immunosuppresseurs - plaque psoriasis tremfya is indicated for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy. psoriatic arthritis tremfya, alone or in combination with methotrexate (mtx), is indicated for the treatment of active psoriatic arthritis in adult patients who have had an inadequate response or who have been intolerant to a prior disease-modifying antirheumatic drug (dmard) therapy (see section 5.
hyperhep b s/d solution
grifols therapeutics llc - immunnoglobuline humaine anti-hépatite b - solution - 220unité - immunnoglobuline humaine anti-hépatite b 220unité - serums
agriflu suspension
seqirus uk limited - hémagglutinine-souche a (h1n1); hémagglutinine-souche a (h3n2); hémaglutinine-souche b - suspension - 15mcg; 15mcg; 15mcg - hémagglutinine-souche a (h1n1) 15mcg; hémagglutinine-souche a (h3n2) 15mcg; hémaglutinine-souche b 15mcg - vaccines
hyperhep b s/d solution
grifols therapeutics llc - immunnoglobuline humaine anti-hépatite b - solution - 220unité - immunnoglobuline humaine anti-hépatite b 220unité - serums
divigel
teva canada limited - estradiol - gel - 0.1% - estradiol 0.1% - estrogens
hyperhep b s/d solution
grifols therapeutics llc - immunnoglobuline humaine anti-hépatite b - solution - 220unité - immunnoglobuline humaine anti-hépatite b 220unité - serums
zabdeno
janssen-cilag international n.v. - recombinant adenovirus type 26 (ad26) encoding the glycoprotein (gp) of the ebola virus zaire (zebov) mayinga strain - fièvre hémorragique À virus ebola - vaccins - active immunization for prevention of disease caused by ebola virus (zaire ebolavirus species) in individuals ≥ 1 year of age.
mvabea
janssen-cilag international n.v. - recombinant modified vaccinia ankara bavarian nordic virus encoding the: ebola virus zaire (zebov) mayinga strain glycoprotein (gp); ebola virus sudan gulu strain gp; ebola virus taï forest strain nucleoprotein and the marburg virus musoke strain gp - fièvre hémorragique À virus ebola - vaccins - active immunization for prevention of disease caused by ebola virus (zaire ebolavirus species) in individuals ≥ 1 year of age.
hertraz™(trastuzumab), 150mg, poudre lyophilisée pour solution pour perfusion, boite de 1 flacon
mylan pharmaceuticals private limited - le trastuzumab - poudre lyophilisée pour solution pour perfusion - 150mg
jcovden (previously covid-19 vaccine janssen)
janssen-cilag international nv - adenovirus type 26 encoding the sars-cov-2 spike glycoprotein (ad26.cov2-s) - covid-19 virus infection - vaccins - jcovden is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 18 years of age and older. l'utilisation de ce vaccin doit être en conformité avec les recommandations officielles.